Market Research Logo

In-vitro Diagnostics Market Size By Type {Product (Reagents & Kits, Instruments), Service (Software, Testing Services)} By Technology (Clinical Chemistry, Immunoassay/Immunochemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostas

In-vitro Diagnostics Market Size By Type {Product (Reagents & Kits, Instruments), Service (Software, Testing Services)} By Technology (Clinical Chemistry, Immunoassay/Immunochemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis), By Application (Oncology, Infectious Diseases, Diabetes, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing/ Pharmacogenomics) By End-User (Hospitals, Point-Of-Care Testing, Laboratories, Academic Institutes), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, UK, Italy, Spain, Russia, China, Japan, India, Australia, Brazil, Mexico, Saudi Arabia, South Africa, UAE), Application Potential, Competitive Market Share & Forecast, 2018 - 2024

In-vitro Diagnostics Market will exceed USD 92 billion by 2024; as per a new research report.

In-vitro diagnostics market should witness considerable growth over the forecast timeframe owing to the growing awareness amongst patients regarding the availability of diagnostic tests. Technology integrated within these devices will improve efficiency of diagnostic devices proving beneficial for the industry growth. Various American organizations such as Center for Chronic Disease Control have implemented certain initiatives that will increase awareness levels for availability of technologically advanced diagnostics among the people that should impact positively in-vitro diagnostics market growth in the upcoming future.

Technologically advanced countries such as Germany and UK focus their efforts on R&D to manufacture automated laboratory diagnostic machines and equipment for accurate detection of diseases. For instance, companies such as Qaigen headquartered in Germany are leaders in providing point of care molecular diagnostics possessing highest accuracy and the results are displayed on the computers for complete analysis. Assays designed by such companies offer quicker and reliable analysis that will encourage its preference over other conventional methods available. However, high cost associated with the diagnostic procedures will hamper in-vitro diagnostics market growth.

Reagents and kits segment held largest market share of 67.7% in 2017 as a result of high prevalence of rare diseases that will have a positive impact on segmental growth. Escalating usage of molecular reagents for detection of various diseases such as Morgellons, Adie syndrome and Crohn disease will boost industry growth over the forecast timeframe. Moreover, key industry players such as Bio-Rad, Beckman Coulter and Cambio emphasize on manufacturing superior quality reagents that aid accurate diagnosis thereby, fosters in-vitro diagnostics industry growth over the forecast timeframe.

Data management software segment will grow at 4.5% CAGR over the projection years due to the increasing development in the software systems. Data management software facilitate the process of diagnosing the patients by providing accurate data at required time thereby influencing the segment growth positively in the near future.

Molecular diagnostics segment accounted for 16.2% revenue share in 2017 and growth can be accounted to high cases of diabetes and other chronic infections that demand critical monitoring. According to International Diabetes Federation in 2017, there were around 7.4 million cases of diabetes in Germany that will increase the demand in upcoming years.

Oncology segment held USD 12.6 billion in 2017 as a result of rising cases of cancer globally. Additionally, growing prevalence of cancer in developing countries such as India will increase the demand for molecular diagnostic reagents and devices. In India, there are around 1.4 million cases of cancer every year that will boost segmental growth over the forecast timeframe.

Hospitals segment of in-vitro diagnostics market held largest revenue share of 30.6% and should expand significantly in the coming years due to increasing number of hospital admissions demanding critical monitoring and accurate diagnosis. According to Statista hospital care expenditures in 2017, was around USD 1,132.6 billion in the U.S. indicating strong demand for in-vitro diagnostics in the upcoming years.

U.S. in-vitro diagnostics market valued at USD 23.9 billion in 2017 and is expected to grow exponentially over the forecast timeframe. According to CDC, around 40% of the Americans expire due to chronic diseases that will enhance industry growth. Moreover, development of favorable reimbursement scenario will drive the business growth significantly.

Some of the prominent industry players operating in in-vitro diagnostics industry is Abbott, Becton Dickinson, BioRad, BioMerieux, Cephied, Danaher, Grifols, Johnson & Johnson, Luminex, Roche Diagnostics, Siemens, Sorin, Thermo Fisher and Qiagen. Strategic initiatives such as new product launch, mergers & acquisition will aid revenue generation for the company. For instance, in April 2017, Abbott declared acquisition of Alere that has enabled Abbott’s point-of-care testing product portfolio that will help Abbott to maintain its market position.


Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. In-vitro diagnostics industry 360 degree synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Type trends
2.1.3. Technology trends
2.1.4. Application trends
2.1.5. End-user trends
2.1.6. Regional trends
Chapter 3. In-vitro Diagnostics Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Growing rate of healthcare infections particularly in North America
3.3.1.2. Increasing adoption rate of automated diagnostic machine & equipment in Europe
3.3.1.3. Rising geriatric population preferring personalized medicines in Asia Pacific
3.3.1.4. Surging number of pathology labs and services equipped with advanced diagnostics machine
3.3.1.5. Increasing awareness regarding viral disease detection in the U.S.
3.3.2. Industry pitfalls and challenges
3.3.2.1. Excessive cost of diagnosis service
3.4. Growth potential analysis
3.4.1. By type
3.4.2. By technology
3.4.3. By application
3.4.4. By end-user
3.5. Regulatory landscape
3.5.1. U.S.
3.5.2. Europe
3.6. Porter's analysis
3.7. Competitive landscape, 2017
3.7.1. Strategy dashboard
3.8. PESTEL analysis
Chapter 4. In-vitro Diagnostics Market, By Type
4.1. Key segment trends
4.2. Product
4.2.1. Market size, by region, 2013-2024 (USD Million)
4.2.2. Reagents & kits
4.2.2.1. Market size, by region, 2013-2024 (USD Million)
4.2.3. Instruments
4.2.3.1. Market size, by region, 2013-2024 (USD Million)
4.3. Service
4.3.1. Market size, by region, 2013-2024 (USD Million)
4.3.2. Software
4.3.2.1. Market size, by region, 2013-2024 (USD Million)
4.3.3. Testing services
4.3.3.1. Market size, by region, 2013-2024 (USD Million)
Chapter 5. In-vitro Diagnostics Market, By Technology
5.1. Key segment trend
5.2. Clinical chemistry
5.2.1. Market size, by region, 2013-2024 (USD Million)
5.3. Immunoassay/immunochemistry
5.3.1. Market size, by region, 2013-2024 (USD Million)
5.4. Molecular diagnostics
5.4.1. Market size, by region, 2013-2024 (USD Million)
5.5. Hematology
5.5.1. Market size, by region, 2013-2024 (USD Million)
5.6. Microbiology
5.6.1. Market size, by region, 2013-2024 (USD Million)
5.7. Coagulation and hemostasis
Market size, by region, 2013-2024 (USD Million)
5.8. Urinalysis
Market size, by region, 2013-2024 (USD Million)
5.9. Others
Market size, by region, 2013-2024 (USD Million)
Chapter 6. In-vitro Diagnostics Market, By Application
6.1. Key segment trend
6.2. Oncology
6.2.1. Market size, by region, 2013-2024 (USD Million)
6.3. Infectious diseases
6.3.1. Market size, by region, 2013-2024 (USD Million)
6.4. Diabetes
6.4.1. Market size, by region, 2013-2024 (USD Million)
6.5. Cardiology
6.5.1. Market size, by region, 2013-2024 (USD Million)
6.6. Nephrology
6.6.1. Market size, by region, 2013-2024 (USD Million)
6.7. Autoimmune diseases
6.7.1. Market size, by region, 2013-2024 (USD Million)
6.8. Drug testing/pharmacogenomics
6.8.1. Market size, by region, 2013-2024 (USD Million)
6.9. Others
6.9.1. Market size, by region, 2013-2024 (USD Million)
Chapter 7. In-vitro Diagnostics Market, By End-user
7.1. Key segment trend
7.2. Hospitals
7.2.1. Market size, by region, 2013-2024 (USD Million)
7.3. Point of care
7.3.1. Market size, by region, 2013-2024 (USD Million)
7.4. Laboratories
7.4.1. Market size, by region, 2013-2024 (USD Million)
7.5. Academic institutes
7.5.1. Market size, by region, 2013-2024 (USD Million)
7.6. Others
7.6.1. Market size, by region, 2013-2024 (USD Million)
Chapter 8. In-vitro Diagnostics Market, By Region
8.1. Key regional market
8.2. North America
8.2.1. Market size, by country, 2013 - 2024(USD Million)
8.2.2. Market size, by type, 2013 - 2024(USD Million)
8.2.2.1. Market size, by product, 2013 - 2024(USD Million)
8.2.2.2. Market size, by service, 2013 - 2024(USD Million)
8.2.3. Market size, by technology, 2013 - 2024(USD Million)
8.2.4. Market size, by application, 2013 - 2024(USD Million)
8.2.5. Market size, by end-user, 2013 - 2024(USD Million)
8.2.6. U.S.
8.2.6.1. Market size, by type, 2013 - 2024(USD Million)
8.2.6.1.1. Market size, by product, 2013 - 2024(USD Million)
8.2.6.1.2. Market size, by service, 2013 - 2024(USD Million)
8.2.6.2. Market size, by technology, 2013 - 2024(USD Million)
8.2.6.3. Market size, by application, 2013 - 2024(USD Million)
8.2.6.4. Market size, by end-user, 2013 - 2024(USD Million)
8.2.7. Canada
8.2.7.1. Market size, by type, 2013 - 2024(USD Million)
8.2.7.1.1. Market size, by product, 2013 - 2024(USD Million)
8.2.7.1.2. Market size, by service, 2013 - 2024(USD Million)
8.2.7.2. Market size, by technology, 2013 - 2024(USD Million)
8.2.7.3. Market size, by application, 2013 - 2024(USD Million)
8.2.7.4. Market size, by end-user, 2013 - 2024(USD Million)
8.3. Europe
8.3.1. Market size, by country, 2013 - 2024(USD Million)
8.3.2. Market size, by type, 2013 - 2024(USD Million)
8.3.2.1. Market size, by product, 2013 - 2024(USD Million)
8.3.2.2. Market size, by service, 2013 - 2024(USD Million)
8.3.3. Market size, by technology, 2013 - 2024(USD Million)
8.3.4. Market size, by application, 2013 - 2024(USD Million)
8.3.5. Market size, by end-user, 2013 - 2024(USD Million)
8.3.6. Germany
8.3.6.1. Market size, by type, 2013 - 2024(USD Million)
8.3.6.1.1. Market size, by product, 2013 - 2024(USD Million)
8.3.6.1.2. Market size, by service, 2013 - 2024(USD Million)
8.3.6.2. Market size, by technology, 2013 - 2024(USD Million)
8.3.6.3. Market size, by application, 2013 - 2024(USD Million)
8.3.6.4. Market size, by end-user, 2013 - 2024(USD Million)
8.3.7. UK
8.3.7.1. Market size, by type, 2013 - 2024(USD Million)
8.3.7.1.1. Market size, by product, 2013 - 2024(USD Million)
8.3.7.1.2. Market size, by service, 2013 - 2024(USD Million)
8.3.7.2. Market size, by technology, 2013 - 2024(USD Million)
8.3.7.3. Market size, by application, 2013 - 2024(USD Million)
8.3.7.4. Market size, by end-user, 2013 - 2024(USD Million)
8.3.8. France
8.3.8.1. Market size, by type, 2013 - 2024(USD Million)
8.3.8.1.1. Market size, by product, 2013 - 2024(USD Million)
8.3.8.1.2. Market size, by service, 2013 - 2024(USD Million)
8.3.8.2. Market size, by technology, 2013 - 2024(USD Million)
8.3.8.3. Market size, by application, 2013 - 2024(USD Million)
8.3.8.4. Market size, by end-user, 2013 - 2024(USD Million)
8.3.9. Italy
8.3.9.1. Market size, by type, 2013 - 2024(USD Million)
8.3.9.1.1. Market size, by product, 2013 - 2024(USD Million)
8.3.9.1.2. Market size, by service, 2013 - 2024(USD Million)
8.3.9.2. Market size, by technology, 2013 - 2024(USD Million)
8.3.9.3. Market size, by application, 2013 - 2024(USD Million)
8.3.9.4. Market size, by end-user, 2013 - 2024(USD Million)
8.3.10. Spain
8.3.10.1. Market size, by type, 2013 - 2024(USD Million)
8.3.10.1.1. Market size, by product, 2013 - 2024(USD Million)
8.3.10.1.2. Market size, by service, 2013 - 2024(USD Million)
8.3.10.2. Market size, by technology, 2013 - 2024(USD Million)
8.3.10.3. Market size, by application, 2013 - 2024(USD Million)
8.3.10.4. Market size, by end-user, 2013 - 2024(USD Million)
8.3.11. Russia
8.3.11.1. Market size, by type, 2013 - 2024(USD Million)
8.3.11.1.1. Market size, by product, 2013 - 2024(USD Million)
8.3.11.1.2. Market size, by service, 2013 - 2024(USD Million)
8.3.11.2. Market size, by technology, 2013 - 2024(USD Million)
8.3.11.3. Market size, by application, 2013 - 2024(USD Million)
8.3.11.4. Market size, by end-user, 2013 - 2024(USD Million)
8.4. Asia Pacific
8.4.1. Market size, by country, 2013 - 2024(USD Million)
8.4.2. Market size, by type, 2013 - 2024(USD Million)
8.4.2.1. Market size, by product, 2013 - 2024(USD Million)
8.4.2.2. Market size, by service, 2013 - 2024(USD Million)
8.4.3. Market size, by technology, 2013 - 2024(USD Million)
8.4.4. Market size, by application, 2013 - 2024(USD Million)
8.4.5. Market size, by end-user, 2013 - 2024(USD Million)
8.4.6. Japan
8.4.6.1. Market size, by type, 2013 - 2024(USD Million)
8.4.6.1.1. Market size, by product, 2013 - 2024(USD Million)
8.4.6.1.2. Market size, by service, 2013 - 2024(USD Million)
8.4.6.2. Market size, by technology, 2013 - 2024(USD Million)
8.4.6.3. Market size, by application, 2013 - 2024(USD Million)
8.4.6.4. Market size, by end-user, 2013 - 2024(USD Million)
8.4.7. China
8.4.7.1. Market size, by type, 2013 - 2024(USD Million)
8.4.7.1.1. Market size, by product, 2013 - 2024(USD Million)
8.4.7.1.2. Market size, by service, 2013 - 2024(USD Million)
8.4.7.2. Market size, by technology, 2013 - 2024(USD Million)
8.4.7.3. Market size, by application, 2013 - 2024(USD Million)
8.4.7.4. Market size, by end-user, 2013 - 2024(USD Million)
8.4.8. India
8.4.8.1. Market size, by type, 2013 - 2024(USD Million)
8.4.8.1.1. Market size, by product, 2013 - 2024(USD Million)
8.4.8.1.2. Market size, by service, 2013 - 2024(USD Million)
8.4.8.2. Market size, by technology, 2013 - 2024(USD Million)
8.4.8.3. Market size, by application, 2013 - 2024(USD Million)
8.4.8.4. Market size, by end-user, 2013 - 2024(USD Million)
8.4.9. Australia
8.4.9.1. Market size, by type, 2013 - 2024(USD Million)
8.4.9.1.1. Market size, by product, 2013 - 2024(USD Million)
8.4.9.1.2. Market size, by service, 2013 - 2024(USD Million)
8.4.9.2. Market size, by technology, 2013 - 2024(USD Million)
8.4.9.3. Market size, by application, 2013 - 2024(USD Million)
8.4.9.4. Market size, by end-user, 2013 - 2024(USD Million)
8.5. Latin America
8.5.1. Market size, by country, 2013 - 2024(USD Million)
8.5.2. Market size, by type, 2013 - 2024(USD Million)
8.5.2.1. Market size, by product, 2013 - 2024(USD Million)
8.5.2.2. Market size, by service, 2013 - 2024(USD Million)
8.5.3. Market size, by technology, 2013 - 2024(USD Million)
8.5.4. Market size, by application, 2013 - 2024(USD Million)
8.5.5. Market size, by end-user, 2013 - 2024(USD Million)
8.5.6. Brazil
8.5.6.1. Market size, by type, 2013 - 2024(USD Million)
8.5.6.1.1. Market size, by product, 2013 - 2024(USD Million)
8.5.6.1.2. Market size, by service, 2013 - 2024(USD Million)
8.5.6.2. Market size, by technology, 2013 - 2024(USD Million)
8.5.6.3. Market size, by application, 2013 - 2024(USD Million)
8.5.6.4. Market size, by end-user, 2013 - 2024(USD Million)
8.5.7. Mexico
8.5.7.1. Market size, by type, 2013 - 2024(USD Million)
8.5.7.1.1. Market size, by product, 2013 - 2024(USD Million)
8.5.7.1.2. Market size, by service, 2013 - 2024(USD Million)
8.5.7.2. Market size, by technology, 2013 - 2024(USD Million)
8.5.7.3. Market size, by application, 2013 - 2024(USD Million)
8.5.7.4. Market size, by end-user, 2013 - 2024(USD Million)
8.6. MEA
8.6.1. Market size, by country, 2013 - 2024(USD Million)
8.6.2. Market size, by type, 2013 - 2024(USD Million)
8.6.2.1. Market size, by product, 2013 - 2024(USD Million)
8.6.2.2. Market size, by service, 2013 - 2024(USD Million)
8.6.3. Market size, by technology, 2013 - 2024(USD Million)
8.6.4. Market size, by application, 2013 - 2024(USD Million)
8.6.5. Market size, by end-user, 2013 - 2024(USD Million)
8.6.6. South Africa
8.6.6.1. Market size, by type, 2013 - 2024(USD Million)
8.6.6.1.1. Market size, by product, 2013 - 2024(USD Million)
8.6.6.1.2. Market size, by service, 2013 - 2024(USD Million)
8.6.6.2. Market size, by technology, 2013 - 2024(USD Million)
8.6.6.3. Market size, by application, 2013 - 2024(USD Million)
8.6.6.4. Market size, by end-user, 2013 - 2024(USD Million)
8.6.7. Saudi Arabia
8.6.7.1. Market size, by type, 2013 - 2024(USD Million)
8.6.7.1.1. Market size, by product, 2013 - 2024(USD Million)
8.6.7.1.2. Market size, by service, 2013 - 2024(USD Million)
8.6.7.2. Market size, by technology, 2013 - 2024(USD Million)
8.6.7.3. Market size, by application, 2013 - 2024(USD Million)
8.6.7.4. Market size, by end-user, 2013 - 2024(USD Million)
8.6.8. UAE
8.6.8.1. Market size, by type, 2013 - 2024(USD Million)
8.6.8.1.1. Market size, by product, 2013 - 2024(USD Million)
8.6.8.1.2. Market size, by service, 2013 - 2024(USD Million)
8.6.8.2. Market size, by technology, 2013 - 2024(USD Million)
8.6.8.3. Market size, by application, 2013 - 2024(USD Million)
8.6.8.4. Market size, by end-user, 2013 - 2024(USD Million)
Chapter 9. Company Profiles
9.1. Abbott
9.1.1. Business overview
9.1.2. Financial data
9.1.3. Product landscape
9.1.4. Strategic outlook
9.1.5. SWOT analysis
9.2. Becton Dickinson
9.2.1. Business overview
9.2.2. Financial data
9.2.3. Product landscape
9.2.4. Strategic outlook
9.2.5. SWOT analysis
9.3. BioRad
9.3.1. Business overview
9.3.2. Financial data
9.3.3. Product landscape
9.3.4. Strategic outlook
9.3.5. SWOT analysis
9.4. BioMerieux
9.4.1. Business overview
9.4.2. Financial data
9.4.3. Product landscape
9.4.4. Strategic outlook
9.4.5. SWOT analysis
9.5. Cephied
9.5.1. Business overview
9.5.2. Financial data
9.5.3. Product landscape
9.5.4. Strategic outlook
9.5.5. SWOT analysis
9.6. Danaher
9.6.1. Business overview
9.6.2. Financial data
9.6.3. Product landscape
9.6.4. Strategic outlook
9.6.5. SWOT analysis
9.7. Grifols
9.7.1. Business overview
9.7.2. Financial data
9.7.3. Product landscape
9.7.4. Strategic outlook
9.7.5. SWOT analysis
9.8. Grifols
9.8.1. Business overview
9.8.2. Financial data
9.8.3. Product landscape
9.8.4. Strategic outlook
9.8.5. SWOT analysis
9.9. Johnson & Johnson
9.9.1. Business overview
9.9.2. Financial data
9.9.3. Product landscape
9.9.4. Strategic outlook
9.9.5. SWOT analysis
9.10. Luminex
9.10.1. Business overview
9.10.2. Financial data
9.10.3. Product landscape
9.10.4. Strategic outlook
9.10.5. SWOT analysis
9.11. Roche Diagnostics
9.11.1. Business overview
9.11.2. Financial data
9.11.3. Product landscape
9.11.4. Strategic outlook
9.11.5. SWOT analysis
9.12. Siemens
9.12.1. Business overview
9.12.2. Financial data
9.12.3. Product landscape
9.12.4. Strategic outlook
9.12.5. SWOT analysis
9.13. Sorin
9.13.1. Business overview
9.13.2. Financial data
9.13.3. Product landscape
9.13.4. Strategic outlook
9.13.5. SWOT analysis
9.14. Thermo Fisher
9.14.1. Business overview
9.14.2. Financial data
9.14.3. Product landscape
9.14.4. Strategic outlook
9.14.5. SWOT analysis
9.15. Qiagen
9.15.1. Business overview
9.15.2. Financial data
9.15.3. Product landscape
9.15.4. Strategic outlook
9.15.5. SWOT analysis
Data Tables
TABLE 1. In-vitro diagnostics industry 360 degree synopsis, 2013 - 2024
TABLE 2. In-vitro diagnostics market, 2013-2017 (USD Million)
TABLE 3. In-vitro diagnostics market, 2018-2024 (USD Million)
TABLE 4. In-vitro diagnostics market, by type, 2013-2017 (USD Million)
TABLE 5. In-vitro diagnostics market, by type, 2018-2024 (USD Million)
TABLE 6. In-vitro diagnostics market, by technology, 2013-2017 (USD Million)
TABLE 7. In-vitro diagnostics market, by technology, 2018-2024 (USD Million)
TABLE 8. In-vitro diagnostics market, by application, 2013-2017 (USD Million)
TABLE 9. In-vitro diagnostics market, by application, 2018-2024 (USD Million)
TABLE 10. In-vitro diagnostics market, by end-user, 2013-2017 (USD Million)
TABLE 11. In-vitro diagnostics market, by end-user, 2018-2024 (USD Million)
TABLE 12. In-vitro diagnostics market, by region, 2013-2017 (USD Million)
TABLE 13. In-vitro diagnostics market, by region, 2018-2024 (USD Million)
TABLE 14. Industry impact forces
TABLE 15. Product market size, by region, 2013 - 2017 (USD Million)
TABLE 16. Product market size, by region, 2018 - 2024 (USD Million)
TABLE 17. Reagents & kits market size, by region, 2018 - 2024 (USD Million)
TABLE 18. Reagents & kits market size, by region, 2018 - 2024 (USD Million)
TABLE 19. Instruments market size, by region, 2013 - 2017 (USD Million)
TABLE 20. Instruments market size, by region, 2018 - 2024 (USD Million)
TABLE 21. Service market size, by region, 2013 - 2017 (USD Million)
TABLE 22. Service market size, by region, 2018 - 2024 (USD Million)
TABLE 23. Software market size, by region, 2013 - 2017 (USD Million)
TABLE 24. Software market size, by region, 2018 - 2024 (USD Million)
TABLE 25. Testing services market size, by region, 2013 - 2017 (USD Million)
TABLE 26. Testing services market size, by region, 2018 - 2024 (USD Million)
TABLE 27. Clinical chemistry market size, by region, 2013 - 2017 (USD Million)
TABLE 28. Clinical chemistry market size, by region, 2018 - 2024 (USD Million)
TABLE 29. Immunoassay/immunochemistry market size, by region, 2013 - 2017 (USD Million)
TABLE 30. Immunoassay/immunochemistry market size, by region, 2018 - 2024 (USD Million)
TABLE 31. Molecular diagnostics market size, by region, 2013 - 2017 (USD Million)
TABLE 32. Molecular diagnostics market size, by region, 2018 - 2024 (USD Million)
TABLE 33. Hematology market size, by region, 2013 - 2017 (USD Million)
TABLE 34. Hematology market size, by region, 2018 - 2024 (USD Million)
TABLE 35. Microbiology market size, by region, 2013 - 2017 (USD Million)
TABLE 36. Microbiology market size, by region, 2018 - 2024 (USD Million)
TABLE 37. Coagulation & Haemostasis market size, by region, 2013 - 2017 (USD Million)
TABLE 38. Coagulation & Haemostasis market size, by region, 2018 - 2024 (USD Million)
TABLE 39. Urinalysis market size, by region, 2013 - 2017 (USD Million)
TABLE 40. Urinalysis market size, by region, 2018 - 2024 (USD Million)
TABLE 41. Others market size, by region, 2013 - 2017 (USD Million)
TABLE 42. Others market size, by region, 2018 - 2024 (USD Million)
TABLE 43. Oncology market size, by region, 2013 - 2017 (USD Million)
TABLE 44. Oncology market size, by region, 2018 - 2024 (USD Million)
TABLE 45. Infectious diseases market size, by region, 2013 - 2017 (USD Million)
TABLE 46. Infectious diseases market size, by region, 2018 - 2024 (USD Million)
TABLE 47. Diabetes market size, by region, 2013 - 2017 (USD Million)
TABLE 48. Diabetes market size, by region, 2018 - 2024 (USD Million)
TABLE 49. Cardiology market size, by region, 2013 - 2017(USD Million)
TABLE 50. Cardiology market size, by region, 2018 - 2024 (USD Million)
TABLE 51. Nephrology market size, by region, 2013 - 2017 (USD Million)
TABLE 52. Nephrology market size, by region, 2018 - 2024 (USD Million)
TABLE 53. Autoimmune diseases market size, by region, 2013 - 2017 (USD Million)
TABLE 54. Autoimmune diseases market size, by region, 2018 - 2024 (USD Million)
TABLE 55. Drug testing/pharmacogenomics market size, by region, 2013 - 2017 (USD Million)
TABLE 56. Drug testing/pharmacogenomics market size, by region, 2018 - 2024 (USD Million)
TABLE 57. Others market size, by region, 2013 - 2017 (USD Million)
TABLE 58. Others market size, by region, 2018 - 2024 (USD Million)
TABLE 59. Hospitals market size, by region, 2013 - 2017 (USD Million)
TABLE 60. Hospitals market size, by region, 2018 - 2024 (USD Million)
TABLE 61. Point of care testing market size, by region, 2013 - 2017 (USD Million)
TABLE 62. Point of care testing market size, by region, 2018 - 2024 (USD Million)
TABLE 63. Laboratories market size, by region, 2013 - 2017 (USD Million)
TABLE 64. Laboratories market size, by region, 2018 - 2024 (USD Million)
TABLE 65. Academic institutes market size, by region, 2013 - 2017 (USD Million)
TABLE 66. Academic institutes market size, by region, 2018 - 2024 (USD Million)
TABLE 67. Others market size, by region, 2013 - 2017 (USD Million)
TABLE 68. Others market size, by region, 2018 - 2024 (USD Million)
TABLE 69. North America in-vitro Diagnostics market size, by country, 2013-2017(USD Million)
TABLE 70. North America in-vitro Diagnostics market size, by country, 2018-2024 (USD Million)
TABLE 71. North America in-vitro Diagnostics market size, by type, 2013-2017, (USD Million)
TABLE 72. North America in-vitro Diagnostics market size, by type, 2018-2024, (USD Million)
TABLE 73. North America in-vitro Diagnostics market size, by technology, 2013-2017, (USD Million)
TABLE 74. North America in-vitro Diagnostics market size, by technology, 2018-2024, (USD Million)
TABLE 75. North America in-vitro Diagnostics market size, by application, 2013-2017, (USD Million)
TABLE 76. North America in-vitro Diagnostics market size, by application, 2018-2024, (USD Million)
TABLE 77. North America in-vitro Diagnostics market size, by end-use, 2013-2017, (USD Million)
TABLE 78. North America in-vitro Diagnostics market size, by end-use, 2018-2024, (USD Million)
TABLE 79. U.S. in-vitro diagnostics market size, by type, 2013-2017, (USD Million)
TABLE 80. U.S. in-vitro diagnostics market size, by type, 2018-2024, (USD Million)
TABLE 81. U.S. in-vitro diagnostics market size, by technology, 2013-2017, (USD Million)
TABLE 82. U.S. in-vitro diagnostics market size, by technology, 2018-2024, (USD Million)
TABLE 83. U.S. in-vitro diagnostics market size, by application, 2013-2017, (USD Million)
TABLE 84. U.S. in-vitro diagnostics market size, by application, 2018-2024, (USD Million)
TABLE 85. U.S. in-vitro diagnostics market size, by end-user, 2013-2017, (USD Million)
TABLE 86. U.S. in-vitro diagnostics market size, by end-user, 2018-2024, (USD Million)
TABLE 87. Canada in-vitro diagnostics market size, by type, 2013-2017, (USD Million)
TABLE 88. Canada in-vitro Diagnostics market size, by type, 2018-2024, (USD Million)
TABLE 89. Canada in-vitro diagnostics market size, by technology, 2013-2017, (USD Million)
TABLE 90. Canada in-vitro diagnostics market size, by technology, 2018-2024, (USD Million)
TABLE 91. Canada in-vitro diagnostics market size, by application, 2013-2017, (USD Million)
TABLE 92. Canada in-vitro diagnostics market size, by application, 2018-2024, (USD Million)
TABLE 93. Canada in-vitro diagnostics market size, by end-user, 2013-2017, (USD Million)
TABLE 94. Canada in-vitro diagnostics market size, by end-user, 2018-2024, (USD Million)
TABLE 95. Europe in-vitro diagnostics market size, by country, 2013-2017 (USD Million)
TABLE 96. Europe in-vitro diagnostics market size, by country, 2018-2024 (USD Million)
TABLE 97. Europe in-vitro diagnostics market, by type, 2013-2017 (USD Million)
TABLE 98. Europe in-vitro diagnostics market, by type, 2018-2024 (USD Million)
TABLE 99. Europe in-vitro diagnostics market, by technology, 2013-2017 (USD Million)
TABLE 100. Europe in-vitro diagnostics market, by technology, 2018-2024 (USD Million)
TABLE 101. Europe in-vitro diagnostics market, by application, 2013-2017 (USD Million)
TABLE 102. Europe in-vitro diagnostics market, by application, 2018-2024 (USD Million)
TABLE 103. Europe in-vitro diagnostics market, by end-user, 2013-2017 (USD Million)
TABLE 104. Europe in-vitro diagnostics market, by end-user, 2018-2024 (USD Million)
TABLE 105. Germany in-vitro diagnostics market, by type, 2013-2017 (USD Million)
TABLE 106. Germany in-vitro diagnostics market, by type, 2018-2024 (USD Million)
TABLE 107. Germany in-vitro diagnostics market, by technology, 2013-2017 (USD Million)
TABLE 108. Germany in-vitro diagnostics market, by technology, 2018-2024 (USD Million)
TABLE 109. Germany in-vitro diagnostics market, by application, 2013-2017 (USD Million)
TABLE 110. Germany in-vitro diagnostics market, by application, 2018-2024 (USD Million)
TABLE 111. Germany in-vitro diagnostics market, by end-user, 2013-2017 (USD Million)
TABLE 112. Germany in-vitro diagnostics market, by end-user, 2018-2024 (USD Million)
TABLE 113. UK in-vitro diagnostics market, by type, 2013-2017 (USD Million)
TABLE 114. UK in-vitro diagnostics market, by type, 2018-2024 (USD Million)
TABLE 115. UK in-vitro diagnostics market, by technology, 2013-2017 (USD Million)
TABLE 116. UK in-vitro diagnostics market, by technology, 2018-2024 (USD Million)
TABLE 117. UK in-vitro diagnostics market, by application, 2013-2017 (USD Million)
TABLE 118. UK in-vitro diagnostics market, by application, 2018-2024 (USD Million)
TABLE 119. UK in-vitro diagnostics market, by end-user, 2013-2017 (USD Million)
TABLE 120. UK in-vitro diagnostics market, by end-user, 2018-2024 (USD Million)
TABLE 121. Italy in-vitro diagnostics market, by type, 2013-2017 (USD Million)
TABLE 122. Italy in-vitro diagnostics market, by type, 2018-2024 (USD Million)
TABLE 123. Italy in-vitro diagnostics market, by technology, 2013-2017 (USD Million)
TABLE 124. Italy in-vitro diagnostics market, by technology, 2018-2024 (USD Million)
TABLE 125. Italy in-vitro diagnostics market, by application, 2013-2017 (USD Million)
TABLE 126. Italy in-vitro diagnostics market, by application, 2018-2024 (USD Million)
TABLE 127. Italy in-vitro diagnostics market, by end-user, 2013-2017 (USD Million)
TABLE 128. Italy in-vitro diagnostics market, by end-user, 2018-2024 (USD Million)
TABLE 129. France in-vitro diagnostics market, by type, 2013-2017 (USD Million)
TABLE 130. France in-vitro diagnostics market, by type, 2018-2024 (USD Million)
TABLE 131. France in-vitro diagnostics market, by technology, 2013-2017 (USD Million)
TABLE 132. France in-vitro diagnostics market, by technology, 2018-2024 (USD Million)
TABLE 133. France in-vitro diagnostics market, by application, 2013-2017 (USD Million)
TABLE 134. France in-vitro diagnostics market, by application, 2018-2024 (USD Million)
TABLE 135. France in-vitro diagnostics market, by end-user, 2013-2017 (USD Million)
TABLE 136. France in-vitro diagnostics market, by end-user, 2018-2024 (USD Million)
TABLE 137. Spain in-vitro diagnostics market, by type, 2013-2017 (USD Million)
TABLE 138. Spain in-vitro diagnostics market, by type, 2018-2024 (USD Million)
TABLE 139. Spain in-vitro diagnostics market, by technology, 2013-2017 (USD Million)
TABLE 140. Spain in-vitro diagnostics market, by technology, 2018-2024 (USD Million)
TABLE 141. Spain in-vitro diagnostics market, by application, 2013-2017 (USD Million)
TABLE 142. Spain in-vitro diagnostics market, by application, 2018-2024 (USD Million)
TABLE 143. Spain in-vitro diagnostics market, by end-user, 2013-2017 (USD Million)
TABLE 144. Spain in-vitro diagnostics market, by end-user, 2018-2024 (USD Million)
TABLE 145. Russia in-vitro diagnostics market, by type, 2013-2017 (USD Million)
TABLE 146. Russia in-vitro diagnostics market, by type, 2018-2024 (USD Million)
TABLE 147. Russia in-vitro diagnostics market, by technology, 2013-2017 (USD Million)
TABLE 148. Russia in-vitro diagnostics market, by technology, 2018-2024 (USD Million)
TABLE 149. Russia in-vitro diagnostics market, by application, 2013-2017 (USD Million)
TABLE 150. Russia in-vitro diagnostics market, by application, 2018-2024 (USD Million)
TABLE 151. Russia in-vitro diagnostics market, by end-user, 2013-2017 (USD Million)
TABLE 152. Russia in-vitro diagnostics market, by end-user, 2018-2024 (USD Million)
TABLE 153. Asia Pacific in-vitro diagnostics market size, by country, 2013-2017 (USD Million)
TABLE 154. Asia Pacific in-vitro diagnostics market size, by country, 2018-2024 (USD Million)
TABLE 155. Asia Pacific in-vitro diagnostics market, by type, 2013-2017 (USD Million)
TABLE 156. Asia Pacific in-vitro diagnostics market, by type, 2018-2024 (USD Million)
TABLE 157. Asia Pacific in-vitro diagnostics market, by technology, 2013-2017 (USD Million)
TABLE 158. Asia Pacific in-vitro diagnostics market, by technology, 2018-2024 (USD Million)
TABLE 159. Asia Pacific in-vitro diagnostics market, by application, 2013-2017 (USD Million)
TABLE 160. Asia Pacific in-vitro diagnostics market, by application, 2018-2024 (USD Million)
TABLE 161. Asia Pacific in-vitro diagnostics market, by end-user, 2013-2017 (USD Million)
TABLE 162. Asia Pacific in-vitro diagnostics market, by end-user, 2018-2024 (USD Million)
TABLE 163. China in-vitro diagnostics market, by type, 2013-2017 (USD Million)
TABLE 164. China in-vitro diagnostics market, by type, 2018-2024 (USD Million)
TABLE 165. China in-vitro diagnostics market, by technology, 2013-2017 (USD Million)
TABLE 166. China in-vitro diagnostics market, by technology, 2018-2024 (USD Million)
TABLE 167. China in-vitro diagnostics market, by application, 2013-2017 (USD Million)
TABLE 168. China in-vitro diagnostics market, by application, 2018-2024 (USD Million)
TABLE 169. China in-vitro diagnostics market, by end-user, 2013-2017 (USD Million)
TABLE 170. China in-vitro diagnostics market, by end-user, 2018-2024 (USD Million)
TABLE 171. India in-vitro diagnostics market, by type, 2013-2017 (USD Million)
TABLE 172. India in-vitro diagnostics market, by type, 2018-2024 (USD Million)
TABLE 173. India in-vitro diagnostics market, by technology, 2013-2017 (USD Million)
TABLE 174. India in-vitro diagnostics market, by techn

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report